Morphological Detection of Liquid-based Thin-layer Film-making Fungi for Fungal Vaginitis in Multiple Hospitals

July 22, 2021 updated by: Yuquan Zhang, Affiliated Hospital of Nantong University

A Multicenter Clinical Study on Liquid-based Morphological Detection of Fungi

The purpose of this study is to compare the results of different detection methods for non-gestational fungal vaginitis (VVC), and to evaluate the significance of different fungal states in the results for diagnosis and treatment.

Study Overview

Detailed Description

The study was divided into two phases: in the first phase, the vaginal secretions of 1000 enrolled patients with fungal vaginitis were detected with 3/4 different methods, and the sensitivity, specificity and consistency of these methods were compared; In the second stage, 1000 patients from the first stage were selected to meet the follow-up stage and divided into two groups. The test of Follow-up fungal culture and fluorescence morphological detection of liquid-based thin-layer film-making fungi were performed periodically. At last, the applicant will analyze the data, write the paper and publish the article.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Anhui
      • Hefei, Anhui, China, 230031
        • The First Affiliated hospital of USTC
    • Guangdong
      • Zhongshan, Guangdong, China
        • Zhongshan City People's Hospital
    • Jiangsu
      • Nantong, Jiangsu, China, 226001
        • The Second Affiliated Hospital of Nantong University
      • Nantong, Jiangsu, China, 226006
        • Affiliated Hospital of Nantong University
      • Nantong, Jiangsu, China
        • Affiliated Nantong Hospital Of Shanghai University
      • Nantong, Jiangsu, China
        • Nantong Maternal and Child Health Hospital
      • Qidong, Jiangsu, China
        • Children's Hospital of Fudan University Qidong Branch
    • Jiangxi
      • Jiujiang, Jiangxi, China
        • Jiujiang Maternal and Child Health Hospital
      • Nanchang, Jiangxi, China, 330006
        • Jiangxi Maternal and Child Health Hospital
    • Shanghai
      • Shanghai, Shanghai, China, 200051
        • Changning District Maternal and Child Health Care Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Female patients with suspected fungal vaginitis.

Description

Inclusion Criteria:

  • 1. Samples from outpatient or inpatient clinics to be tested for fungal vaginitis.
  • 2. A sample of one or more of the following characteristics. 2.1 Symptoms: vulva pruritus, burning pain, but also accompanied by pain in urine and sexual pain and other symptoms; Leucorrhea increased.

2.2 Physical signs: Vulva flushing, edema, visible scratches or chaps, white membrane attached to the inner side of the labia minora and the vaginal mucosa, more white bean residue like secretions can be seen in the vagina, which can be curd.

  • 3. The samples are vaginal secretions from the female body. Each sample should be the amount on one swab.
  • 4. The sample is not in menstrual period.
  • 5. The sample subjects did not have vaginal irrigation, medication or sexual intercourse within 3 days.

Exclusion Criteria:

  • 1. Cases with incomplete specimen collection;
  • 2. Mixed vaginitis cases;
  • 3. Abscission cases with incomplete follow-up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
life-style counseling

A sample of one or more of the following characteristics. Symptoms: vulva pruritus, burning pain, but also accompanied by pain in urine and sexual pain and other symptoms; Leucorrhea increased.

Physical signs: Vulva flushing, edema, visible scratches or chaps, white membrane attached to the inner side of the labia minora and the vaginal mucosa, more white bean residue like secretions can be seen in the vagina, which can be curd.

Samples from outpatient or inpatient clinics to be tested for fungal vaginitis. A sample of one or more of the following characteristics. Symptoms: vulva pruritus, burning pain, but also accompanied by pain in urine and sexual pain and other symptoms; Leucorrhea increased.

Physical signs: Vulva flushing, edema, visible scratches or chaps, white membrane attached to the inner side of the labia minora and the vaginal mucosa, more white bean residue like secretions can be seen in the vagina, which can be curd.

Samples are human vaginal secretions. Each sample should be the amount on one swab.

The sample is not in menstrual period. The sample subjects did not have vaginal irrigation, medication or sexual intercourse within 3 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparing the positive detection rate of 3/4 different detection methods in the first phase.
Time Frame: From Aug. 1st to Dec. 31st, 2021
The positive coincidence rate (sensitivity), negative coincidence rate (specificity) and total coincidence rate (consistency) was compared, according to the P<0.05 was used to determine whether it was statistically significant.
From Aug. 1st to Dec. 31st, 2021
Calculating the proportion of the number of fungi in three different states in the map results of three/four detection methods.
Time Frame: From Aug. 1st, 2021 to Jan. 31st, 2022
Counting The number and proportion of mycelia, spores and blastospores, especially the percentage of cases of single spore (+) in all cases of fungus (+).
From Aug. 1st, 2021 to Jan. 31st, 2022
Counting the positive numbers of 4 or 6 liquid-based thin-layer fungal fluorescence morphological tests and fungal culture in the Stage 2_follow-up stage.
Time Frame: From Mar. 1, 2022 to Dec. 31st, 2022
the positive coincidence rate (sensitivity), negative coincidence rate (specificity) of 4 or 6 liquid-based thin-layer fungal fluorescence morphological tests
From Mar. 1, 2022 to Dec. 31st, 2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yuquan Zhang, Doctor, Affiliated Hospital of Nantong University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 9, 2021

Primary Completion (Anticipated)

December 31, 2022

Study Completion (Anticipated)

April 1, 2023

Study Registration Dates

First Submitted

July 22, 2021

First Submitted That Met QC Criteria

July 22, 2021

First Posted (Actual)

July 30, 2021

Study Record Updates

Last Update Posted (Actual)

July 30, 2021

Last Update Submitted That Met QC Criteria

July 22, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AHNantongU_YEZH_NTFS_V1.0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Not planning sharing at present.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaginitis

Subscribe